Literature DB >> 25412781

Psoriasis and the life cycle of persistent life effects.

Marisa Kardos Garshick1, Alexa Boer Kimball2.   

Abstract

Psoriasis is associated with significant physical, social, and behavioral comorbidities that create a substantial burden. We outline herein that these comorbidities start early in life and persist for decades, ultimately impacting the entire life course of patients with psoriasis. By highlighting the ages that psoriasis patients are affected with physical, social, behavioral and emotional comorbidities, we demonstrate the age-appropriate considerations for psoriasis patients.

Entities:  

Keywords:  Life effects; Physical comorbidities; Psoriasis; Psychological comorbidities; Stigma

Mesh:

Year:  2015        PMID: 25412781     DOI: 10.1016/j.det.2014.09.003

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

1.  MicroRNA-520a suppresses the proliferation and mitosis of HaCaT cells by inactivating protein kinase B.

Authors:  Rui Wang; Zigang Zhao; Liqiang Zheng; Xiaojing Xing; Wei Ba; Junfen Zhang; Min Huang; Wenwei Zhu; Bing Liu; Xianfu Meng; Jia Bai; Chengxin Li; Hengjin Li
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

2.  Psoriasis: The Poster Child for Bench-to-bedside Translational Medicine.

Authors:  Lotus Mallbris; Brian J Nickoloff
Journal:  J Clin Aesthet Dermatol       Date:  2015-07

Review 3.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

4.  Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease.

Authors:  Melodie Young; Heather L Roebuck
Journal:  J Am Assoc Nurse Pract       Date:  2016-11-21       Impact factor: 1.165

5.  The Lived Experience of Psoriasis Patients from Social Stigma and Rejection: A Qualitative Study.

Authors:  Alireza Ghorbanibirgani; Masoud Fallahi-Khoshknab; Kourosh Zarea; Heidarali Abedi
Journal:  Iran Red Crescent Med J       Date:  2016-05-21       Impact factor: 0.611

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.